Author

R.W. Humphrey

Observed names: R W Humphrey, Rachel W. Humphrey

Observed institutions: National Institutes of Health, National Cancer Institute of Thailand, National Cancer Institute

OpenAlex ID: A5111643690

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

1995 · M.W. Saville, J. Lietzau, et al. · The Lancet · 202

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.

1998 · L Welles, M W Saville, et al. · Journal of Clinical Oncology · 173

Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology

1997 · R W Humphrey, A Ohagen, et al. · Antimicrobial Agents and Chemotherapy · 18

A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection

1999 · Rachel W. Humphrey, Kathleen M. Wyvill, et al. · Antiviral Research · 11

Clinical Effects of MGCD265, an oral Tyrosine Kinase Inhibitor, in Combination with Erlotinib or Docetaxel for Treatment of Advanced Gastroesophageal and Nsclc Tumors

2012 · A. Patnaik, K. Papadopoulos, et al. · Annals of Oncology

Works count: 5

Citation count: 404

H-index: 4

I10-index: 4